BUFURALOL 1'-HYDROXYLASE ACTIVITY OF THE RAT - STRAIN DIFFERENCES AND THE EFFECTS OF INHIBITORS

被引:35
作者
BOOBIS, AR
SEDDON, CE
DAVIES, DS
机构
关键词
D O I
10.1016/0006-2952(86)90493-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:2961 / 2965
页数:5
相关论文
共 22 条
[1]   ANIMAL MODELING OF HUMAN POLYMORPHIC DRUG OXIDATION - THE METABOLISM OF DEBRISOQUINE AND PHENACETIN IN RAT INBRED STRAINS [J].
ALDABBAGH, SG ;
IDLE, JR ;
SMITH, RL .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1981, 33 (03) :161-164
[2]   MONO-OXYGENASE ACTIVITY OF HUMAN-LIVER IN MICROSOMAL FRACTIONS OF NEEDLE-BIOPSY SPECIMENS [J].
BOOBIS, AR ;
BRODIE, MJ ;
KAHN, GC ;
FLETCHER, DR ;
SAUNDERS, JH ;
DAVIES, DS .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (01) :11-19
[3]  
BOOBIS AR, 1983, MOL PHARMACOL, V23, P474
[4]   GENETIC-POLYMORPHISM IN DRUG OXIDATION - INVITRO STUDIES OF HUMAN DEBRISOQUINE 4-HYDROXYLASE AND BUFURALOL 1'-HYDROXYLASE ACTIVITIES [J].
BOOBIS, AR ;
MURRAY, S ;
HAMPDEN, CE ;
DAVIES, DS .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (01) :65-71
[5]   EVIDENCE FOR AN ENZYMATIC DEFECT IN THE 4-HYDROXYLATION OF DEBRISOQUINE BY HUMAN-LIVER [J].
DAVIES, DS ;
KAHN, GC ;
MURRAY, S ;
BRODIE, MJ ;
BOOBIS, AR .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (01) :89-91
[6]   THE GENETIC-CONTROL OF BUFURALOL METABOLISM IN MAN [J].
DAYER, P ;
BALANT, L ;
COURVOISIER, F ;
KUPFER, A ;
KUBLI, A ;
GORGIA, A ;
FABRE, J .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1982, 7 (01) :73-77
[7]  
DISTLERATH LM, 1985, J BIOL CHEM, V260, P9057
[8]   CHARACTERIZATION OF A HUMAN-LIVER CYTOCHROME-P-450 INVOLVED IN THE OXIDATION OF DEBRISOQUINE AND OTHER DRUGS BY USING ANTIBODIES RAISED TO THE ANALOGOUS RAT ENZYME [J].
DISTLERATH, LM ;
GUENGERICH, FP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (23) :7348-7352
[9]  
DISTLERATH LM, 1985, MICROSOMES DRUG OXID, P380
[10]   POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES [J].
EICHELBAUM, M ;
BERTILSSON, L ;
SAWE, J ;
ZEKORN, C .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) :184-186